MedPath

NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
🇺🇸United States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Completed
Conditions
Atherosclerosis
Type 2 Diabetes (T2D)
First Posted Date
2016-05-03
Last Posted Date
2020-11-13
Lead Sponsor
NYU Langone Health
Target Recruit Count
279
Registration Number
NCT02759289
Locations
🇺🇸

New York University School of Medicine, New York, New York, United States

Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome

Phase 2
Completed
Conditions
Epilepsy
Interventions
Drug: ataluren
Drug: Placebo
First Posted Date
2016-05-02
Last Posted Date
2023-02-16
Lead Sponsor
NYU Langone Health
Target Recruit Count
15
Registration Number
NCT02758626
Locations
🇺🇸

New York University School of Medicine, New York, New York, United States

Quantitative MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male

Not Applicable
Withdrawn
Conditions
Infertility
Interventions
Device: MRI
First Posted Date
2016-04-29
Last Posted Date
2019-01-29
Lead Sponsor
NYU Langone Health
Registration Number
NCT02756325

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Phase 2
Withdrawn
Conditions
Glioblastoma
Glioma
Interventions
Drug: Bevacizumab
Biological: Peptide Vaccine
Drug: Poly-ICLC as immune adjuvant
Drug: Keyhole limpet hemocyanin (KLH)
First Posted Date
2016-04-28
Last Posted Date
2020-01-13
Lead Sponsor
NYU Langone Health
Registration Number
NCT02754362
Locations
🇺🇸

NYU Perlmutter Cancer Center, New York, New York, United States

Dexamethasone as an Immediate Intervention

Phase 1
Withdrawn
Conditions
Trauma
Interventions
First Posted Date
2016-04-27
Last Posted Date
2017-12-14
Lead Sponsor
NYU Langone Health
Registration Number
NCT02753166
Locations
🇺🇸

New York University Medical Center, New York, New York, United States

Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer

Phase 2
Active, not recruiting
Conditions
Breast Cancer
Interventions
First Posted Date
2016-04-27
Last Posted Date
2024-03-06
Lead Sponsor
NYU Langone Health
Target Recruit Count
70
Registration Number
NCT02752685
Locations
🇺🇸

NYU Perlmutter Cancer Center, New York, New York, United States

Home Based Adaptive Arm Training for Children

Not Applicable
Terminated
Conditions
Hemiplegia
Interventions
Device: m2 Bimanual Arm Trainer (BAT)
First Posted Date
2016-04-26
Last Posted Date
2022-02-11
Lead Sponsor
NYU Langone Health
Target Recruit Count
4
Registration Number
NCT02751502
Locations
🇺🇸

New York University Langone Medical Center, New York, New York, United States

fMRI Guided TMS Enhancement of Associative Memory Networks

Not Applicable
Terminated
Conditions
Epilepsy
Interventions
Diagnostic Test: MagStim RapidStim2
First Posted Date
2016-04-25
Last Posted Date
2024-05-29
Lead Sponsor
NYU Langone Health
Target Recruit Count
8
Registration Number
NCT02749422
Locations
🇺🇸

New York University School of Medicine, New York, New York, United States

Early Independent Adaptive Arm and Hand Rehab

Not Applicable
Completed
Conditions
Post-stroke Hemiparesis
Interventions
Other: Conventional Occupational Therapy (OT)
Device: m2 BAT
First Posted Date
2016-04-25
Last Posted Date
2019-03-25
Lead Sponsor
NYU Langone Health
Target Recruit Count
6
Registration Number
NCT02749500
Locations
🇺🇸

New York University Langone Medical Center, New York, New York, United States

CSII Pilot in Adolescents With Type 2 Diabetes

Not Applicable
Terminated
Conditions
Diabetes
Interventions
Other: MMT 723
First Posted Date
2016-04-22
Last Posted Date
2019-09-17
Lead Sponsor
NYU Langone Health
Target Recruit Count
6
Registration Number
NCT02748122
Locations
🇺🇸

New York University Langone Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath